Skip to Content Facebook Feature Image

HK Media’s Jiangsu Tour: Aidea Pharmaceutical's HIV Drug Breakthrough Sets Sights on the World

China

HK Media’s Jiangsu Tour: Aidea Pharmaceutical's HIV Drug Breakthrough Sets Sights on the World
China

China

HK Media’s Jiangsu Tour: Aidea Pharmaceutical's HIV Drug Breakthrough Sets Sights on the World

2026-04-05 15:00

The Hong Kong media delegation visited Jiangsu Aidea Pharmaceutical Co., Ltd. on March 25. Ms. Liu Yan, the corporation's Board Secretary, introduced the latest commercial progress of the corporation's two Class 1 innovative anti-HIV drugs. Ms. Liu also stated that the corporation plans to list in Hong Kong in the long term, aiming to leverage the city's financing flexibility to support clinical trials in the U.S. and expansion into the African market.

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

From AIDS Fighter to STAR Market Listing: Aidea's Rise

More Images
Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Founded in Yangzhou in 2009, Aidea Pharmaceutical Co., Ltd., listed on the STAR Market in 2020, and remains the only corporation from Yangzhou currently listed on the exchange. According to Ms. Liu, the corporation's founder started the business in Guangzhou in the previous years. After selling Guangdong Techpool Biopharma Co., Ltd., the founder returned to the hometown of Yangzhou to establish Aidea Pharmaceutical Co., Ltd.

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

The corporation's English name, "Aidea," was jokingly interpreted by the media as "Aidea, the AIDS fighter" based on the similarity of Chinese pronunciation when the corporation first went public. "It seems destined that we would achieve something in this field," Ms. Liu said.

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Ms. Liu Yan, the corporation's Board Secretary, Photo by Bastille Post

Filling the Gap, Doubling Revenue: Aidea's Two Innovative Drugs Deliver

China currently has four innovative oral anti-HIV drugs on the market, and Aidea Pharmaceutical owns two of them: Ainuovirine Tablets (Aibangde) and Ainuomiti Tablets (Fubangde). The former is the first domestically developed Class 1 oral anti-HIV drug, while the latter is the only domestically produced triple-combination drug, requiring just one tablet every 24 hours.

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

According to Ms. Liu, among the more than one million HIV patients in China, approximately 60–70% still use free generic drugs. However, the market penetration rate of innovative drugs continues to rise, and she predicts the overall market size will reach 11 billion RMB by 2027. She revealed that Aidea's HIV business revenue has doubled annually for nearly four years — soaring from just 33 million RMB in 2022 to nearly 300 million RMB in 2025.

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

Aidea's Innovative HIV Drugs: Just 70 RMB per Patient

Ms. Liu specifically highlighted Fubangde as an example. The suggested monthly price is 724 RMB, but after medical insurance reimbursement, patients in some provinces actually pay as little as 70 RMB.

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

She described how free generic drugs, while effective at suppressing the virus, can lead to long-term side effects such as insomnia, depression, and headaches. "Although lifespan has increased, the quality of life has severely declined," she said. In contrast, Aidea's innovative drugs offer significant advantages in safety and convenience. Relevant clinical data from the corporation has been published in top international journals.

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

The drug products released by Aidea Pharmaceutical Co., Ltd., Photo by Bastille Post

Accelerates U.S. Clinical Trials, Explores International Financing Channels

Regarding the R&D Pipeline, Ms. Liu highlighted ACC017, an integrase inhibitor comparable to Gilead's globally bestselling HIV drug. The product has entered Phase III clinical trials, and the corporation is currently in discussions with the U.S. FDA, with plans to launch U.S. clinical trials next year. The corporation has announced a refinancing plan of no more than 1.277 billion RMB, with the raised funds primarily allocated to clinical expenses and related R&D in the U.S. market.

Regarding a potential Hong Kong listing, Ms. Liu described it as a "future consideration", noting that the corporation's current A-share market capitalization stands at less than 10 billion RMB. Nevertheless, she believes Hong Kong offers distinct advantages in terms of international financing flexibility and overseas capital flow. "Hong Kong's refinancing is very flexible," she said. "A corporation can issue shares five or six times in a year, which is basically impossible in the A-share market."

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

In late March, the Hong Kong media delegation visited the Confucius Temple, Qinhuai River, Slender West Lake, the Yangzhou China Grand Canal Museum, and the Suzhou Pingjiang Historical and Cultural District, following the Grand Canal and waterways from various dynasties. Appreciating lantern festivals, classical gardens, ancient streets, and the timeworn waters, the delegation experienced the cultural heritage of Jiangnan in early spring and witnessed the preservation of the world's cultural heritage sites.

Photo by Bastille Post

Photo by Bastille Post

Nanjing: Qinhuai River's Glimmering Lanterns

On the evening of March 23, the delegation boarded an ornately decorated boat from the Confucius Temple and traveled along the Qinhuai River.

On the water, lotus lanterns, cicada lanterns, rabbit lanterns, and lanterns depicting ladies in ancient costumes and zodiac animals swayed with ripples. The docent explained, "The Qinhuai Lantern Festival and Qinhuai lantern decorations are both national intangible cultural heritage. The classic Qinhuai lantern designs include lotus lanterns, cicada lanterns, and rabbit lanterns, etc." The Qinhuai Lantern Festival, revived in 1984, is now in its 40th year, with the theme "A Thousand Years of Lanterns Illuminating Jinling, A New Chapter Begins at 40th Year." The festival features eight exhibition areas and approximately 390 lantern sets.

On the water, lotus lanterns, cicada lanterns, rabbit lanterns, and lanterns depicting ladies in ancient costumes and zodiac animals swayed with ripples. Photo by Bastille Post

On the water, lotus lanterns, cicada lanterns, rabbit lanterns, and lanterns depicting ladies in ancient costumes and zodiac animals swayed with ripples. Photo by Bastille Post

The firewalls of the Hui-style buildings on both banks rose high into the night. The docent explained that the firewalls were "both aesthetically pleasing and, due to their height, provided excellent fire prevention".

Photo by Bastille Post

Photo by Bastille Post

The boat passed Wende Bridge, famous for its alignment with the meridian. Every year on the fifteenth day of the eleventh lunar month at midnight, the bridge's shadow perfectly splits the moon's reflection in the river in two, with half the moon visible on each side — a phenomenon known as "Wende Dividing the Moon."

The Confucius Temple is crowded with visitors. Photo by Bastille Post

The Confucius Temple is crowded with visitors. Photo by Bastille Post

According to folklore, the poet Li Bai, while drinking at a tavern near the bridge, saw the moon's reflection in the water and leapt from the bridge in an attempt to catch it, thus adding fame to this extraordinary sight.

Yangzhou: The Enduring Grace of Classical Gardens and Ancient Waterways

On the evening of March 25, the delegation boarded a boat in Yangzhou for a night cruise on Slender West Lake.

Tracing back to history, when Emperor Qianlong traveled south by water, Slender West Lake lay along his imperial route. As the emperor passed through, the salt merchants of Yangzhou vied to build a garden along the shores. Whoever built a more beautiful garden would have the emperor's procession slow down before theirs for appreciation. Driven by the competition, one garden after another rose along the shores, until the lake landscape became "flowers and willows lining both shores, pavilions and terraces stretching all the way to the mountains."

The beautiful scenery of the Slender West Lake at night, Photo by Bastille Post

The beautiful scenery of the Slender West Lake at night, Photo by Bastille Post

The docent introduced the history of the Five Pavilion Bridge, the Twenty-Four Bridges, and the Fishing Terrace along the lake. The Five Pavilion Bridge, whose official name is "Lotus Bridge", was originally built during the Qianlong era. The existing White Pagoda and the bridge foundation of the Five Pavilion Bridge are authentic Qing Dynasty relics; the rest were rebuilt after being destroyed during the Taiping Rebellion.

The White Pagoda, Photo by Bastille Post

The White Pagoda, Photo by Bastille Post

The docent remarked, "The beauty of Slender West Lake during the day is visible at a glance, but its beauty at night must be comprehended." The lake features a water curtain performance titled "Two Parts of the Moon", inspired by the Tang Dynasty poem: "Of the three parts of the moonlit night under heaven, two parts belong to Yangzhou." Using lights and water mist, the performance brings to life the poetic imagery that scholars have sung of for centuries.

The water curtain performance at night, Photo by Bastille Post

The water curtain performance at night, Photo by Bastille Post

The following day, the delegation visited Jianzhen Road and the Grand Canal Museum. Jianzhen Road is named after the Tang Dynasty monk Jianzhen, a native of Yangzhou who travelled six times to Japan to spread Buddhism. During the flowering season, cherry blossoms bloom along the road, accompanied by creative markets and Hanfu (traditional Han clothing) photography events.

The statue of the Tang Dynasty monk Jianzhen, Photo by Bastille Post

The statue of the Tang Dynasty monk Jianzhen, Photo by Bastille Post

The Yangzhou China Grand Canal Museum, located in the Sanwan Scenic Spot, is a national first-class museum. It houses over 10,000 artifacts related to the Grand Canal, spanning from the Spring and Autumn Period to the present day. A key exhibit is a 25-meter-long cross-section of the Bian River channel, retrieved intact from an archaeological site in Henan Province. Layers of bed soil from different dynasties are stacked, allowing visitors to see a cross-section of time itself.

The Yangzhou China Grand Canal Museum, Photo by Bastille Post

The Yangzhou China Grand Canal Museum, Photo by Bastille Post

A key exhibit is a 25-meter-long cross-section of the Bian River channel, retrieved intact from an archaeological site in Henan Province. Photo by Bastille Post

A key exhibit is a 25-meter-long cross-section of the Bian River channel, retrieved intact from an archaeological site in Henan Province. Photo by Bastille Post

The museum houses over 10,000 artifacts related to the Grand Canal, spanning from the Spring and Autumn Period to the present day. Photo by Bastille Post

The museum houses over 10,000 artifacts related to the Grand Canal, spanning from the Spring and Autumn Period to the present day. Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Moreover, the museum also features a digital immersive exhibition titled "Love of the River". In 2014, Yangzhou led 35 cities along the Grand Canal in successfully applying for UNESCO World Cultural Heritage status.

The exhibits at the museum, Photo by Bastille Post

The exhibits at the museum, Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Suzhou: Spring Breathes Life into Ancient Streets and Winding Waters

On the afternoon of March 28, the delegation visited the Suzhou Pingjiang Historical and Cultural District.

Pingjiang Road is approximately 1,600 meters long, and its layout closely matches the Pingjiangtu, a city map of Suzhou in the Song Dynasty. The double-chessboard structure of "parallel waterways and land, streets adjacent to rivers" from the Tang and Song Dynasties has been preserved to the present, earning it the UNESCO Asia-Pacific Heritage Conservation Award.

Photo by Bastille Post

Photo by Bastille Post

In the springtime, tourists and locals enjoyed themselves along Pingjiang Road, which is not a deliberately constructed tourist attraction, but a living ancient street where people still reside, run shops, and go about their daily lives. Some were even dressed in traditional costumes, strolling amidst the lively atmosphere.

Photo by Bastille Post

Photo by Bastille Post

Near the parking area stands a building hidden within the campus of Suzhou Pingjiang Experimental School — the Dacheng Hall of Changzhou County School, the main hall of the county school. Originally built in the Song Dynasty, the current structure is a reconstruction from the Guangxu period of the Qing Dynasty, sharing the same site with the present-day school. 

The Dacheng Hall of Changzhou County School, Photo by Bastille Post

The Dacheng Hall of Changzhou County School, Photo by Bastille Post

As the trip drew to a close, the delegation moved to a lakeside in Suzhou, appreciating the beauty of the flower season and spring scenery.

Photo by Bastille Post

Photo by Bastille Post

Ancient streets and waterways lay on one side, while the springtime lakeside was on the other. One side held a landscape spanning over two thousand years; the other held a modern spring afternoon. Each simply rested in its own tranquility to form a peaceful harmony.

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Photo by Bastille Post

Recommended Articles